540 related articles for article (PubMed ID: 30161253)
41. Bacterial citrullinated epitopes generated by
Jenning M; Marklein B; Ytterberg J; Zubarev RA; Joshua V; van Schaardenburg D; van de Stadt L; Catrina AI; Nonhoff U; Häupl T; Konthur Z; Burmester GR; Skriner K
Ann Rheum Dis; 2020 Sep; 79(9):1194-1202. PubMed ID: 32532752
[TBL] [Abstract][Full Text] [Related]
42. Clinical and immunological aspects of anti-peptidylarginine deiminase type 4 (anti-PAD4) autoantibodies in rheumatoid arthritis.
Reyes-Castillo Z; Muñoz-Valle JF; Llamas-Covarrubias MA
Autoimmun Rev; 2018 Feb; 17(2):94-102. PubMed ID: 29196243
[TBL] [Abstract][Full Text] [Related]
43. Applicability of Small-Molecule Inhibitors in the Study of Peptidyl Arginine Deiminase 2 (PAD2) and PAD4.
Martín Monreal MT; Rebak AS; Massarenti L; Mondal S; Šenolt L; Ødum N; Nielsen ML; Thompson PR; Nielsen CH; Damgaard D
Front Immunol; 2021; 12():716250. PubMed ID: 34737738
[TBL] [Abstract][Full Text] [Related]
44. Synovial fluid is a site of citrullination of autoantigens in inflammatory arthritis.
Kinloch A; Lundberg K; Wait R; Wegner N; Lim NH; Zendman AJ; Saxne T; Malmström V; Venables PJ
Arthritis Rheum; 2008 Aug; 58(8):2287-95. PubMed ID: 18668562
[TBL] [Abstract][Full Text] [Related]
45. Activation of Peptidylarginine Deiminase in the Salivary Glands of
Rodríguez-Rodríguez M; Herrera-Esparza R; Bollain Y Goytia JJ; Pérez-Pérez ME; Pacheco-Tovar D; Murillo-Vázquez J; Pacheco-Tovar G; Avalos-Díaz E
J Immunol Res; 2017; 2017():8959687. PubMed ID: 29318161
[TBL] [Abstract][Full Text] [Related]
46. Citrullination of fibrinogen by peptidylarginine deiminase 2 impairs fibrin clot structure.
Damiana T; Damgaard D; Sidelmann JJ; Nielsen CH; de Maat MPM; Münster AB; Palarasah Y
Clin Chim Acta; 2020 Feb; 501():6-11. PubMed ID: 31730822
[TBL] [Abstract][Full Text] [Related]
47. Expression of citrulline and homocitrulline residues in the lungs of non-smokers and smokers: implications for autoimmunity in rheumatoid arthritis.
Lugli EB; Correia RE; Fischer R; Lundberg K; Bracke KR; Montgomery AB; Kessler BM; Brusselle GG; Venables PJ
Arthritis Res Ther; 2015 Jan; 17(1):9. PubMed ID: 25600626
[TBL] [Abstract][Full Text] [Related]
48. Release of Active Peptidyl Arginine Deiminases by Neutrophils Can Explain Production of Extracellular Citrullinated Autoantigens in Rheumatoid Arthritis Synovial Fluid.
Spengler J; Lugonja B; Ytterberg AJ; Zubarev RA; Creese AJ; Pearson MJ; Grant MM; Milward M; Lundberg K; Buckley CD; Filer A; Raza K; Cooper PR; Chapple IL; Scheel-Toellner D
Arthritis Rheumatol; 2015 Dec; 67(12):3135-45. PubMed ID: 26245941
[TBL] [Abstract][Full Text] [Related]
49. [The pathogenic role of ACPA in rheumatoid arthritis].
Umeda N; Matsumoto I; Sumida T
Nihon Rinsho Meneki Gakkai Kaishi; 2017; 40(6):391-395. PubMed ID: 29367523
[TBL] [Abstract][Full Text] [Related]
50. Citrullinated Inhibitor of DNA Binding 1 Is a Novel Autoantigen in Rheumatoid Arthritis.
Ohara RA; Edhayan G; Rasmussen SM; Isozaki T; Remmer HA; Lanigan TM; Campbell PL; Urquhart AG; Lawton JN; Chung KC; Fox DA; Ruth JH
Arthritis Rheumatol; 2019 Aug; 71(8):1241-1251. PubMed ID: 30861322
[TBL] [Abstract][Full Text] [Related]
51. Autoimmunity to specific citrullinated proteins gives the first clues to the etiology of rheumatoid arthritis.
Wegner N; Lundberg K; Kinloch A; Fisher B; Malmström V; Feldmann M; Venables PJ
Immunol Rev; 2010 Jan; 233(1):34-54. PubMed ID: 20192991
[TBL] [Abstract][Full Text] [Related]
52. Extracellular traps and PAD4 released by macrophages induce citrullination and auto-antibody production in autoimmune arthritis.
El Shikh MEM; El Sayed R; Nerviani A; Goldmann K; John CR; Hands R; Fossati-Jimack L; Lewis MJ; Pitzalis C
J Autoimmun; 2019 Dec; 105():102297. PubMed ID: 31277965
[TBL] [Abstract][Full Text] [Related]
53. Prevalence of soluble peptidylarginine deiminase 4 (PAD4) and anti-PAD4 antibodies in autoimmune diseases.
Umeda N; Matsumoto I; Kawaguchi H; Kurashima Y; Kondo Y; Tsuboi H; Ogishima H; Suzuki T; Kagami Y; Sakyu T; Ishigami A; Maruyama N; Sumida T
Clin Rheumatol; 2016 May; 35(5):1181-8. PubMed ID: 26415740
[TBL] [Abstract][Full Text] [Related]
54. Insights into the study and origin of the citrullinome in rheumatoid arthritis.
Fert-Bober J; Darrah E; Andrade F
Immunol Rev; 2020 Mar; 294(1):133-147. PubMed ID: 31876028
[TBL] [Abstract][Full Text] [Related]
55. Peptidylarginine Deiminase 2 in Murine Antiviral and Autoimmune Antibody Responses.
Mergaert AM; Denny MF; Kingstad-Bakke B; Bawadekar M; Bashar SJ; Warner TF; Suresh M; Shelef MA
J Immunol Res; 2022; 2022():5258221. PubMed ID: 35083342
[TBL] [Abstract][Full Text] [Related]
56. Reactive oxygen species inhibit catalytic activity of peptidylarginine deiminase.
Damgaard D; Bjørn ME; Jensen PØ; Nielsen CH
J Enzyme Inhib Med Chem; 2017 Dec; 32(1):1203-1208. PubMed ID: 28933232
[TBL] [Abstract][Full Text] [Related]
57. Increased citrullination of histone H3 in multiple sclerosis brain and animal models of demyelination: a role for tumor necrosis factor-induced peptidylarginine deiminase 4 translocation.
Mastronardi FG; Wood DD; Mei J; Raijmakers R; Tseveleki V; Dosch HM; Probert L; Casaccia-Bonnefil P; Moscarello MA
J Neurosci; 2006 Nov; 26(44):11387-96. PubMed ID: 17079667
[TBL] [Abstract][Full Text] [Related]
58. Characterization and use of the ECV304 autoantigenic citrullinome to understand anti-citrullinated protein/peptide autoantibodies in rheumatoid arthritis.
de França NR; Ménard HA; Lora M; Zhou Z; Rauch J; Hitchon C; Andrade LEC; Colmegna I
Arthritis Res Ther; 2022 Jan; 24(1):23. PubMed ID: 35027076
[TBL] [Abstract][Full Text] [Related]
59. Reduced glutathione as a physiological co-activator in the activation of peptidylarginine deiminase.
Damgaard D; Bjørn ME; Steffensen MA; Pruijn GJ; Nielsen CH
Arthritis Res Ther; 2016 May; 18(1):102. PubMed ID: 27149996
[TBL] [Abstract][Full Text] [Related]
60. Subjects at-risk for future development of rheumatoid arthritis demonstrate a PAD4-and TLR-dependent enhanced histone H3 citrullination and proinflammatory cytokine production in CD14
Okamato Y; Ghosh T; Okamoto T; Schuyler RP; Seifert J; Charry LL; Visser A; Feser M; Fleischer C; Pedrick C; August J; Moss L; Bemis EA; Norris JM; Kuhn KA; Demoruelle MK; Deane KD; Ghosh D; Holers VM; Hsieh EWY
J Autoimmun; 2021 Feb; 117():102581. PubMed ID: 33310262
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
